Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 69,180 |
|
|||||
| News | - | ||||||
| Day High | 0.3358 | Low High |
|||||
| Day Low | 0.321 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Coeptis Therapeutics Holdings Inc | COEP | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.007 | -2.14% | 0.32 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.321 | 0.321 | 0.3358 | 0.322 | 0.327 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 118 | 69,180 | $ 0.3245948 | $ 22,455 | - | 0.2851 - 2.1899 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:50:11 | formt | 100 | $ 0.32 | USD |
Coeptis Therapeutics Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 407.59M | 34.11M | - | 0 | -21.27M | -0.62 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Coeptis Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical COEP Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.3699 | 0.3799 | 0.321 | 0.3362408 | 105,504 | -0.0499 | -13.49% |
| 1 Month | 0.291 | 0.48 | 0.2851 | 0.3687024 | 297,416 | 0.029 | 9.97% |
| 3 Months | 0.59 | 0.679 | 0.2851 | 0.4392127 | 272,242 | -0.27 | -45.76% |
| 6 Months | 1.34 | 1.38 | 0.2851 | 0.608594 | 198,079 | -1.02 | -76.12% |
| 1 Year | 1.27 | 2.1899 | 0.2851 | 0.9783561 | 162,838 | -0.95 | -74.80% |
| 3 Years | 8.20 | 8.7551 | 0.2851 | 1.29 | 185,439 | -7.88 | -96.10% |
| 5 Years | 8.20 | 8.7551 | 0.2851 | 1.29 | 185,439 | -7.88 | -96.10% |
Coeptis Therapeutics Description
| Coeptis Therapeutics Holdings, Inc., a biopharmaceutical company, develops cell therapy platforms for patients with cancer. Its product portfolio consists of CD38-GEAR-NK, a cell therapy for the treatment of CD38-related cancers, including multiple myeloma, chronic lymphocytic leukemia, and acute myeloid leukemia; SNAP-CAR, a CAR T cell therapy platform co-administered with tagged, tumor-specific antibodies to potentially target different tumor types, including hematological malignancies and solid tumors; and CD38-Diagnostic, an in vitro screening tool to analyze if cancer patients might be appropriate candidates for anti-CD38 mAb therapy. The company has collaboration with Statera BioPharma to develop and commercialize STAT-201 for Crohn's disease; and Vici Health Sciences, LLC to co-develop and share ownership rights to CPT60621 for the treatment of Parkinson's Disease. Coeptis Therapeutics Holdings, Inc. is headquartered in Wexford, Pennsylvania. |
